resumo
Phytopharmaceuticals have been widely used globally since ancient times and acknowledged by healthcare professionals and patients for their superior therapeutic value and fewer side-effects compared to modern medicines. However, phytopharmaceuticals need a scientific and methodical approach to deliver their components and thereby improve patient compliance and treatment adherence. Dose reduction, improved bioavailability, receptor selective binding, and targeted delivery of phytopharmaceuticals can be likely achieved by molding them into specific nano-formulations. In recent decades, nanotechnology-based phytopharmaceuticals have emerged as potential therapeutic candidates for the treatment of various communicable and non-communicable diseases. Nanotechnology combined with phytopharmaceuticals broadens the therapeutic perspective and overcomes problems associated with plant medicine. The current review highlights the therapeutic application of various nano-phytopharmaceuticals in neurological, cardiovascular, pulmonary, and gastro-intestinal disorders. We conclude that nano-phytopharmaceuticals emerge as promising therapeutics for many pathological conditions with good compliance and higher acceptance.
palavras-chave
H1N1 INFLUENZA-VIRUS; SILVER NANOPARTICLES; IN-VITRO; METALLIC NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; GOLD NANOPARTICLES; GREEN SYNTHESIS; PANAX-GINSENG; CURCUMIN
categoria
Chemistry; Science & Technology - Other Topics; Materials Science; Physics
autores
Lim, CL; Raju, CS; Mahboob, T; Kayesth, S; Gupta, KK; Jain, GK; Dhobi, M; Nawaz, M; Wilairatana, P; Pereira, MD; Patra, JK; Paul, AK; Rahmatullah, M; Nissapatorn, V
nossos autores
Maria de Lourdes Gomes Pereira
Professor Associado com Agregaçãoagradecimentos
M.d.L.P. thanks Project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 and UIDP/50011/2020, national funds by FCT/MCTES. J.K.P. is grateful to the National Research Foundation of Korea [NRF] grant funded by the Korea government (MSIT) (No. 2020R1G1A1004667), the Republic of Korea for support.